Cerner (CERN) Receives Consensus Recommendation of “Hold” from Analysts

Cerner (NASDAQ:CERN) has received a consensus recommendation of “Hold” from the twenty-three brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and ten have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $66.16.

CERN has been the subject of a number of recent research reports. Zacks Investment Research upgraded Cerner from a “sell” rating to a “hold” rating in a research note on Tuesday, December 26th. Cantor Fitzgerald restated a “buy” rating and issued a $80.00 target price on shares of Cerner in a research note on Monday, March 5th. BidaskClub lowered Cerner from a “sell” rating to a “strong sell” rating in a research note on Thursday, March 15th. Bank of America initiated coverage on Cerner in a research note on Tuesday, February 27th. They issued a “buy” rating and a $75.00 target price for the company. Finally, Evercore ISI started coverage on Cerner in a research note on Thursday, January 18th. They issued an “in-line” rating and a $77.00 target price for the company.

How to Become a New Pot Stock Millionaire

Shares of NASDAQ CERN opened at $56.42 on Friday. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.01 and a quick ratio of 2.99. The firm has a market capitalization of $18,765.12, a P/E ratio of 25.41, a PEG ratio of 1.64 and a beta of 0.96. Cerner has a one year low of $55.29 and a one year high of $73.86.

Cerner (NASDAQ:CERN) last issued its earnings results on Tuesday, February 6th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.03). The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.61 earnings per share. equities analysts anticipate that Cerner will post 2.42 EPS for the current year.

In other news, Director William D. Zollars sold 4,100 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $62.16, for a total transaction of $254,856.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Jeffrey A. Townsend sold 230,000 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $61.94, for a total value of $14,246,200.00. The disclosure for this sale can be found here. Insiders have sold 541,800 shares of company stock worth $34,353,860 in the last 90 days. Company insiders own 13.11% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. Icon Wealth Partners LLC bought a new stake in shares of Cerner during the fourth quarter worth $107,000. Steward Partners Investment Advisory LLC bought a new stake in shares of Cerner during the third quarter worth $128,000. Cerebellum GP LLC bought a new stake in shares of Cerner during the fourth quarter worth $127,000. Delpha Capital Management LLC bought a new position in Cerner in the fourth quarter valued at about $144,000. Finally, Virtue Capital Management LLC bought a new position in Cerner in the fourth quarter valued at about $197,000. Institutional investors own 78.54% of the company’s stock.

WARNING: This report was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/04/08/cerner-cern-receives-consensus-recommendation-of-hold-from-analysts.html.

About Cerner

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply